MBNL1 and neoplasm: Our findings help in the elucidation of the molecular mechanism by which dysregulated mTORC1 signaling drives tumor angiogenesis, indicating that the components in the STAT3/miR-130b-3p/MBNL1 loop signaling pathway may be targeted for the treatment of mTORC1-related tumors.